PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

IQWiG: First health economic evaluation completed

Report on health economic evaluation of antidepressants provides very helpful results; discussion is still pending about the future role of health economic evaluations in the health-care system

2013-10-30
(Press-News.org) Contact information: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
IQWiG: First health economic evaluation completed Report on health economic evaluation of antidepressants provides very helpful results; discussion is still pending about the future role of health economic evaluations in the health-care system The German Institute for Quality and Efficiency in Health Care (IQWiG) has completed its first health economic evaluation. The report on antidepressants published on 30 October 2013 shows that the "efficiency frontier method" works and can provide very helpful results. In relation to their benefit, some drugs are markedly more expensive than others. The self-government of the German health care system can now be provided with well-founded information on the appropriate price at which the statutory health insurance (SHI) funds could reimburse a drug. It is now the responsibility of politicians to discuss and determine the future relevance of such evaluations in the health care system.

Complete health economic evaluation not possible for all drugs due to lack of data

In the present health economic evaluation IQWiG was commissioned by the Federal Joint Committee (G-BA) to determine the cost-effectiveness ratio of venlafaxine, duloxetine, bupropion, and mirtazapine compared to other currently available drugs and to placebo. For this purpose, the efficiency frontier method, which was adapted by IQWiG and an international expert panel, was applied. With this method, a price or price corridor can be determined within which a drug can be regarded as "cost-effective".

However, due to missing data it was not possible to present the results on an efficiency frontier for all drugs and all patient-relevant outcomes (e.g. quality of life) and derive prices adjusted for added benefit.

Prices markedly higher than appropriate

IQWiG was able to calculate such "added-benefit-adjusted reimbursement prices" for the outcomes "response" (to treatment), defined as a reduction in depressive symptoms of at least 50% on a disease-specific scale, and "remission". The latter is achieved if symptoms can be alleviated to an extent that the criteria for depression are no longer fulfilled.

The relation between their benefit for patients and the price reimbursed by the SHI funds shows marked differences between drugs; this applies to both outcomes. For each of the 4 drugs assessed, the current reimbursement price is higher than the "appropriate" price inferred from the respective efficiency frontier. However, 2 of the drugs assessed (mirtazapine and venlafaxine) have since been classified into a reference price group, meaning that the current price of each drug will probably have shifted closer to the efficiency frontier.

Legal situation has changed

The results of this health economic evaluation are not directly relevant to decision making, neither for drug prices nor for general reimbursement. This is due to a change in the legal situation since the report was commissioned. Originally, the results were supposed to form the basis of the decision on the setting of a "maximum reimbursable price" for drugs. This was the responsibility of the SHI umbrella organization ("GKV-Spitzenverband").

Since the introduction of the Act on the Reform of the Market for Medicinal Products (AMNOG), a health economic evaluation is primarily planned for the case where price negotiations fail after the regular early benefit assessment and where the arbitral verdict is also challenged. In this case the drug manufacturers or the SHI umbrella organization can apply for a health economic evaluation.

Successful test run

Despite the change in the legal situation, it was important for the Institute to complete the report. As the Institute's Director Jürgen Windeler explains: "We wanted to test whether the efficiency frontier method, which is the method preferred by IQWIG, is suitable and leads to robust results. And this test was successful. The report shows drug manufacturers and SHI funds what they can expect from a health economic evaluation and what not."

Challenges remain

IQWiG was also able to gain important experiences in this test run and identify open questions. For instance, it is still debatable how different aspects of benefit and harm, e.g. side effects, should be weighted and aggregated to an overall conclusion. One option is to use patient preferences. IQWiG has therefore tested methods on how to determine such preferences.

In addition, a lack of data was noticeable; on the cost side this applies, among other things, to SHI claims data, which are not freely available in Germany.

But gaps were also evident on the benefit side: on average, studies investigating the benefit of antidepressants lasted only 8 weeks. This time horizon, however, neither sufficiently reflects the treatment situation of patients affected by major depression, nor informs the self-government, as its decisions cannot be based on such a short period.

Important component for decisions in the health care system

Jürgen Windeler is certain that "the results of the health economic evaluation can nevertheless represent an important component in price negotiations and decisions on reimbursement. But we now need a discussion on the relevance of this component for decisions in the health care system. This will also represent a challenge for the new Minister of Health. The discussion also has to address the amount of resources that should be invested. This investment may be considerable, at least as long as cost data are not standardized. However, thanks to the experiences we have gained in the meantime, further health economic evaluations will probably be performed much faster."

INFORMATION:

Process of report production

IQWiG published the preliminary results in the form of the preliminary report in November 2012 and interested parties were invited to submit comments. Following a request from drug manufacturers, IQWiG prolonged the scheduled deadline by 4 weeks, which had never happened before in the Institute's assessments. At the end of the commenting procedure the preliminary report was revised and sent as a final report to the commissioning agency, the Federal Joint Committee (G-BA), in September 2013. The submitted written comments were published in a separate document at the same time as the final report. The report was produced in collaboration with external experts.

The English-language executive summary provides an overview of the background, procedures and further results of the report.

END



ELSE PRESS RELEASES FROM THIS DATE:

Gimball: A crash-happy flying robot

2013-10-30
Gimball: A crash-happy flying robot Gimball bumps into and ricochets off of obstacles, rather than avoiding them. This 34 centimeter in diameter spherical flying robot buzzes around the most unpredictable, chaotic environments, without ...

Type 2 diabetes: New associations identified between genes and metabolic markers

2013-10-30
Type 2 diabetes: New associations identified between genes and metabolic markers In two comprehensive studies, scientists from Helmholtz Zentrum Muenchen, Ludwig-Maximilians-Universitaet ...

RNA build-up linked to dementia and motor neuron disease

2013-10-30
RNA build-up linked to dementia and motor neuron disease A new toxic entity associated with genetically inherited forms of dementia and motor neuron disease has been identified by scientists at the UCL Institute of Neurology. The toxin is the result of a genetic ...

Weight loss not always beneficial for romantic relationships

2013-10-30
Weight loss not always beneficial for romantic relationships Losing weight is generally beneficial for human health, but when one partner in a romantic relationship loses weight, it doesn't always have a positive effect on the relationship. According to ...

Future Internet aims to sever links with servers

2013-10-30
Future Internet aims to sever links with servers A revolutionary new architecture aims to make the Internet more 'social' by eliminating the need to connect to servers and enabling all content to be shared more efficiently Researchers have taken the first step ...

Children with diplegic and hemiplegic cerebral palsy: Who can be paid more attention by rehabilitation physicians?

2013-10-30
Children with diplegic and hemiplegic cerebral palsy: Who can be paid more attention by rehabilitation physicians? Improving standing balance in children with cerebral palsy is crucial to improve cognitive and motor functions. Studies have shown differences in sitting ...

Study: Models to predict scientists' future impact often fail

2013-10-30
Study: Models to predict scientists' future impact often fail Models universities partially use to forecast scientists' future contributions are not as reliable as previously thought. In a recent study, Aalto University and IMT Institute for Advanced Studies ...

Persons with Alzheimer's are more likely to suffer from heart disease -- yet offered less treatment options than others

2013-10-30
Persons with Alzheimer's are more likely to suffer from heart disease -- yet offered less treatment options than others Persons with Alzheimer's disease suffer from ischaemic heart diseases more frequently than others, yet they undergo related ...

Improving light and heat spectra measurements

2013-10-30
Improving light and heat spectra measurements PTB software for industry and research can be downloaded free of charge Whether you want to investigate objects in space, characterize the quality of light sources, optimize photovoltaics ...

Recycling valuable materials used in TVs, car batteries, cell phones

2013-10-30
Recycling valuable materials used in TVs, car batteries, cell phones Many of today's technologies, from hybrid car batteries to flat-screen televisions, rely on materials known as rare earth elements (REEs) that are in short supply, but scientists are reporting ...

LAST 30 PRESS RELEASES:

Music-based therapy may improve depressive symptoms in people with dementia

No evidence that substituting NHS doctors with physician associates is necessarily safe

At-home brain speed tests bridge cognitive data gaps

CRF appoints Josep Rodés-Cabau, M.D., Ph.D., as editor-in-chief of structural heart: the journal of the heart team

Violent crime is indeed a root cause of migration, according to new study

Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment

Impact of COVID-19 on education not going away, UM study finds

School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods

Three Speculum articles recognized with prizes

ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology

Incarcerated people are disproportionately impacted by climate change, CU doctors say

ESA 2025 Graduate Student Policy Award Cohort Named

Insomnia, lack of sleep linked to high blood pressure in teens

Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults

Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk

Large study of dietary habits suggests more plant oils, less butter could lead to better health

Butter and plant-based oils intake and mortality

20% of butterflies in the U.S. have disappeared since 2000

Bacterial ‘jumping genes’ can target and control chromosome ends

Scientists identify genes that make humans and Labradors more likely to become obese

Early-life gut microbes may protect against diabetes, research in mice suggests

Study raises the possibility of a country without butterflies

Study reveals obesity gene in dogs that is relevant to human obesity studies

A rapid decline in US butterfly populations

Indigenous farming practices have shaped manioc’s genetic diversity for millennia

Controlling electrons in molecules at ultrafast timescales

Tropical forests in the Americas are struggling to keep pace with climate change

Brain mapping unlocks key Alzheimer’s insights

Clinical trial tests novel stem-cell treatment for Parkinson’s disease

Awareness of rocky mountain spotted fever saves lives

[Press-News.org] IQWiG: First health economic evaluation completed
Report on health economic evaluation of antidepressants provides very helpful results; discussion is still pending about the future role of health economic evaluations in the health-care system